Works matching DE "OMALIZUMAB"

Results: 465

Case Report: Omalizumab combined with voriconazole for the treatment of ABPA complicating IPA: a case report.

Published in:

2025

By:

Zhao, Tingrui;
Chen, Yukai;
Sun, He

Publication type:

Case Study

Challenging Clinical Therapeutic Approach to Urticarial Vasculitis: A Case Series.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 13, p. 4580, doi. 10.3390/jcm14134580

By:

Artosi, Fabio;
Cosio, Terenzio;
Diluvio, Laura;
Costanza, Gaetana;
Coniglione, Filadelfo;
Iacovantuono, Maria;
Matteini, Enrico;
Kaya, Elif Çağla;
Lambiase, Sara;
Bianchi, Luca;
Campione, Elena

Publication type:

Article

Comparative Analysis of ICS Combined with LABA versus Addition of Omalizumab on Transcriptomic Expression Profiles in Patients with Allergic Asthma.

Published in:

Journal of Asthma & Allergy, 2025, v. 18, p. 941, doi. 10.2147/JAA.S511885

By:

Liang, Ya-Ru;
Chang, Chuan-Hsin;
Huang, Shiang-Yu;
Wu, Yao-Kuang;
Yang, Mei-Chen;
Huang, Kuo-Liang;
Tzeng, -Shiang;
Hsieh, Po-Chun;
Lan, Chou-Chin

Publication type:

Article

A 10-Year Real-World Analysis of Omalizumab Use in Chronic Spontaneous Urticaria Patients at a Dermatology Clinic.

Published in:

Medical Bulletin of Sisli Etfal Hospital, 2025, v. 59, n. 2, p. 194, doi. 10.14744/SEMB.2025.79059

By:

Cetinkaya, Pinar Ozdemir;
Arslan, Zulkuf;
Dirliktutan, Berkay;
Karaosmanoglu, Nermin

Publication type:

Article

Interval prolongation is an effective and well-tolerated approach when stepping down omalizumab treatment in chronic spontaneous urticaria.

Published in:

Archives of Dermatological Research, 2025, v. 317, n. 1, p. 1, doi. 10.1007/s00403-025-04328-2

By:

Köylüce, Serpil;
Açar, Elif;
Şeker, Serhat;
Yılmaz, Hatice Eylül Bozkurt;
Yapıcı, Elif Aktaş;
Arslan, Bahar;
Yılmaz, Insu;
Türk, Murat

Publication type:

Article

Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study.

Published in:

Clinical & Experimental Allergy, 2025, v. 55, n. 6, p. 481, doi. 10.1111/cea.70067

By:

Soegiharto, Reineke;
Van der Wind, Esther;
Alizadeh Aghdam, Mehran;
Sørensen, Jennifer A.;
Van Lindonk, Esmee;
Bulut Demir, Ferhan;
Mohammad Porras, Nasser;
Matsuo, Yoshimi;
Kiefer, Lea;
Knulst, André C.;
Maurer, Marcus;
Ritchie, Carla;
Rudenko, Michael;
Kocatürk, Emek;
Fachini Jardim Criado, Roberta;
Gregoriou, Stamatis;
Bobylev, Tatjana;
Kleinheinz, Andreas;
Takahagi, Shunsuke;
Hide, Michihiro

Publication type:

Article

Omalizumab pretreatment in a case of pediatric carboplatin desensitization.

Published in:

Pediatric Allergy & Immunology, 2025, v. 36, n. 6, p. 1, doi. 10.1111/pai.70136

By:

Brozyna, Jeremy Richard;
Patel, Reena;
Fancher, William Bradford;
Anderson, John;
CaJacob, Amy

Publication type:

Article

Omalizumab in pediatric chronic spontaneous urticaria: A systematic review and meta‐analysis of efficacy and safety.

Published in:

Pediatric Allergy & Immunology, 2025, v. 36, n. 6, p. 1, doi. 10.1111/pai.70132

By:

Alomari, Omar;
Ozceker, Deniz;
Mokresh, Muhammed Edib;
Topçak, Asli Berivan;
Ertan, Sinem Nur;
Şahin, Merve Karaca;
Çalışkan, Nilay;
Karadag, Sefika Ilknur Kökcü;
Erbay, Muhammed Fatih;
Yıldırım, Güler;
Bologur, Hamit;
Güngör, Hilal;
Kaplan, Ozlem;
Tunç, Hasan Sarman;
Göncü, Emek Kocatürk

Publication type:

Article

AAAAI 2025: Omalizumab Shows Favorable Outcomes Versus Oral Immunotherapy in Multi‐Food Allergy Treatment.

Published in:

Patient Care (Online), 2025, p. 8

By:

Jennings, Sydney

Publication type:

Article

Omalizumab Granted First FDA Indication for Children and Adults with Multiple Food Allergies.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Impact of Omalizumab Treatment on Quality of Life and Activity of Chronic Spontaneous Urticaria.

Published in:

Eurasian Journal of Critical Care, 2024, v. 6, n. 1, p. 25, doi. 10.55994/ejcc.1467724

By:

KASAP, Nurhan;
ORCEN, Cihan

Publication type:

Article

The effect of COVID-19 pandemic on treatment compliance and process of chronic urticaria patients receiving omalizumab treatment.

Published in:

Medicine Science, 2021, v. 10, n. 3, p. 764, doi. 10.5455/medscience.2021.02.044

By:

Aytekin, Gokhan;
Atayik, Emel

Publication type:

Article

Aktuální pohled na urtikarii - příčiny jejího vzniku, diagnostika a aktuální možnosti v léčbě.

Published in:

Dermatologie Pro Praxi, 2022, v. 16, n. 1, p. 13

By:

Jankovičová, Barbora

Publication type:

Article

Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 18, p. 5610, doi. 10.3390/jcm13185610

By:

Calzari, Paolo;
Chiei Gallo, Alessandra;
Barei, Francesca;
Bono, Eleonora;
Cugno, Massimo;
Marzano, Angelo Valerio;
Ferrucci, Silvia Mariel

Publication type:

Article

Omalizumab and Dupilumab for the Treatment of Bullous Pemphigoid: A Systematic Review.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 16, p. 4844, doi. 10.3390/jcm13164844

By:

Granados-Betancort, Elena;
Sánchez-Díaz, Manuel;
Muñoz-Barba, Daniel;
Arias-Santiago, Salvador

Publication type:

Article

Assessment of ELR, PLR, NLR and BLR Ratios during Omalizumab Treatment of Chronic Spontaneous Urticaria.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4287, doi. 10.3390/jcm13154287

By:

Branicka, Olga;
Rymarczyk, Barbara;
Gawlik, Radosław;
Glück, Joanna

Publication type:

Article

Chronic Urticaria Treatment with Omalizumab—Verification of NLR, PLR, SIRI and SII as Biomarkers and Predictors of Treatment Efficacy.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 7, p. 2639, doi. 10.3390/jcm12072639

By:

Tarkowski, Bartłomiej;
Ławniczak, Julia;
Tomaszewska, Katarzyna;
Kurowski, Marcin;
Zalewska-Janowska, Anna

Publication type:

Article

IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 1, p. 378, doi. 10.3390/jcm12010378

By:

Maronese, Carlo Alberto;
Ferrucci, Silvia Mariel;
Moltrasio, Chiara;
Lorini, Maurizio;
Carbonelli, Vincenzo;
Asero, Riccardo;
Marzano, Angelo Valerio;
Cugno, Massimo

Publication type:

Article

Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 15, p. 4453, doi. 10.3390/jcm11154453

By:

Manti, Sara;
Giallongo, Alessandro;
Papale, Maria;
Parisi, Giuseppe Fabio;
Leonardi, Salvatore

Publication type:

Article

Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study.

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1822, doi. 10.3390/jcm11071822

By:

Grieco, Teresa;
Ambrosio, Luca;
Trovato, Federica;
Vitiello, Martina;
Demofonte, Ilaria;
Fanto, Marta;
Paolino, Giovanni;
Pellacani, Giovanni

Publication type:

Article

The Long-Term Effectiveness of Omalizumab in Adult Patients with Severe Allergic Asthma: Continuous Treatment Versus Boosting Treatment.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 4, p. 707, doi. 10.3390/jcm10040707

By:

Huang, Wei-Chang;
Fu, Pin-Kuei;
Chan, Ming-Cheng;
Chin, Chun-Shih;
Huang, Wen-Nan;
Lai, Kuo-Lung;
Wang, Jiun-Long;
Hung, Wei-Ting;
Wu, Yi-Da;
Hsieh, Chia-Wei;
Wu, Ming-Feng;
Chen, Yi-Hsing;
Hsu, Jeng-Yuan;
Sohal, Sukhwinder Singh

Publication type:

Article

A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-91463-5

By:

Song, Yongfu;
Wang, Zhuang;
Wang, Na;
Xie, Xiaofei;
Zhu, Tieshi;
Wang, Yongji

Publication type:

Article

Saudi Arabian real-life experience with biologic therapy in severe asthma.

Published in:

Multidisciplinary Respiratory Medicine, 2021, v. 16, p. 1, doi. 10.4081/mrm.2021.807

By:

Eldaboussi, Safwat;
Qabil, Ahmed;
Lotfi, Ahmed;
Awad, Amgad;
Abdel Salam, Eman;
Alkhamis, Abdullah;
Abuelhassan, Usama E.

Publication type:

Article

Bioequivalence Between a New Omalizumab Prefilled Syringe With an Autoinjector or with a Needle Safety Device Compared with the Current Prefilled Syringe: A Randomized Controlled Trial in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 611, doi. 10.1002/cpdd.1373

By:

Sangana, Ramachandra;
Xu, Yan;
Shah, Bharti;
Tian, Xianbin;
Zack, Julia;
Shakeri‐Nejad, Kasra;
Kalluri, Sampath;
Jones, Ieuan;
Ligueros‐Saylan, Monica;
Taylor, Angel Fowler;
Jain, Devendra Kumar;
Scosyrev, Emil;
Uddin, Alkaz;
Laurent, Nathalie;
Paganoni, Paola

Publication type:

Article

A Randomized, Single‐Dose, Parallel‐Controlled Phase 1 Clinical Comparison of an Omalizumab Biosimilar Candidate with Reference Omalizumab in Healthy Chinese Male Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 349, doi. 10.1002/cpdd.1350

By:

Cheng, Jie;
Wang, Chenguang;
Xu, Jin;
Zhao, Chunyang;
Song, Rong;
Wang, Yijun;
Zou, Yang;
Zhang, Xunmin;
Shan, Yong;
Zhou, Jian;
Jia, Jing‐Ying

Publication type:

Article

Comparison of the therapeutic effects of medication therapy, specific immunotherapy and anti-IgE (Omalizumab) in patients with hay fever.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1363034

By:

Rui Tang;
Xiaohong Lyu;
Yibo Hou;
Yongshi Yang;
Guodong Fu;
Liping Zhu;
Lu Xue;
Hong Li;
Ruiqi Wang

Publication type:

Article

Biological treatment for bullous pemphigoid.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1157250

By:

Oren-Shabtai, Meital;
Mimouni, Daniel;
Nosrati, Adi;
Atzmony, Lihi;
Kaplan, Baruch;
Barzilai, Aviv;
Baum, Sharon

Publication type:

Article

Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis.

Published in:

Lung (0341-2040), 2024, v. 202, n. 4, p. 367, doi. 10.1007/s00408-024-00717-y

By:

Chen, Xiaoying;
Zhi, Haopeng;
Wang, Xiaohu;
Zhou, Zicong;
Luo, Huiting;
Li, Jing;
Sehmi, Roma;
O'Byrne, Paul M.;
Chen, Ruchong

Publication type:

Article

A localized salt‐dependent aquagenic urticaria successfully treated with omalizumab.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 12, p. 2339, doi. 10.1111/ced.15346

By:

Carra, Sophie;
Dereure, Olivier;
Raison‐Peyron, Nadia

Publication type:

Article

'It has given me my life back': a qualitative study exploring the lived experience of patients with chronic spontaneous urticaria on omalizumab.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 11, p. 2032, doi. 10.1111/ced.15321

By:

Porter, Emma;
Tierney, Emma;
Byrne, Berbie;
Basheer‐O'Dwyer, Sarah;
Kanaan, Ansam;
Ramsay, Bart;
Field, Sinéad

Publication type:

Article

Cost‐effectiveness of personalized omalizumab dosing for chronic spontaneous urticaria.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 11, p. 2002, doi. 10.1111/ced.15316

By:

Denman, Sarah;
Smith, Helin;
Arumugakani, Gururaj;
Mistry, Anoop;
Savic, Sinisa

Publication type:

Article

Atypical Wiskott–Aldrich syndrome without thrombocytopenia partially responding to omalizumab therapy.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 5, p. 1013, doi. 10.1111/ced.15119

By:

Gupta, Priyansh;
Subburaj, Kirutika;
Jindal, Ankur;
Rawat, Amit;
Rikhi, Rashmi;
De, Dipankar;
Handa, Sanjeev;
Mahajan, Rahul

Publication type:

Article

Successful treatment of severe recalcitrant vernal keratoconjunctivitis and atopic dermatitis associated with elevated IgE levels with omalizumab.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 604, doi. 10.1111/ced.15000

By:

Zengarini, C.;
Roda, M.;
Schiavi, C.;
Bruni, F.;
Bardazzi, F.;
Bellusci, C.;
Raone, B.

Publication type:

Article

Methotrexate combined with omalizumab for difficult to treat urticaria: a further step‐up treatment?

Published in:

Clinical & Experimental Dermatology, 2021, v. 46, n. 2, p. 350, doi. 10.1111/ced.14359

By:

Garbayo‐Salmons, P.;
Butt, S.;
Dawe, R. S.

Publication type:

Article

Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair<sup>®</sup>).

Published in:

Clinical & Experimental Dermatology, 2018, v. 43, n. 5, p. 573, doi. 10.1111/ced.13408

By:

Hughes, J. D. M.;
Olynyc, T.;
Chapdelaine, H.;
Segal, L.;
Miedzybrodzki, B.;
Ben‐Shoshan, M.

Publication type:

Article

Efficacy and safety of CT‐P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16‐week follow‐up study.

Published in:

Clinical & Translational Allergy, 2025, v. 15, n. 6, p. 1, doi. 10.1002/clt2.70069

By:

Grattan, Clive;
Dytyatkovska, Yevgeniya;
Springer, Michał;
Ratkova, Maria;
Krusheva, Borislava;
Krupa‐Borek, Izabella;
Pulka, Grazyna;
Chełmińska, Marta;
Reich, Adam;
Kim, Sunghyun;
Bae, Yunju;
Kim, Suyoung;
Lee, Sewon;
An, Eunjin;
Park, Jeong Eun;
Ka, Jieun;
Kim, Jongho;
Saini, Sarbjit S.

Publication type:

Article

Biological and target synthetic treatments for chronic spontaneous urticaria: A systematic review and network meta‐analysis.

Published in:

Clinical & Translational Allergy, 2025, v. 15, n. 5, p. 1, doi. 10.1002/clt2.70052

By:

Zhao, Zuotao;
Zheng, Yaqi;
Song, Xiaoting;
Peng, Chengyue;
Liao, Shuanglu;
Zhang, Peixin;
Tan, Yen;
Huang, Xiaojie;
Zhang, Litao

Publication type:

Article

A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown‐CSU study.

Published in:

Clinical & Translational Allergy, 2024, v. 14, n. 2, p. 1, doi. 10.1002/clt2.12343

By:

Türk, Murat;
Kocatürk, Emek;
Ertaş, Ragıp;
Ensina, Luis Felipe;
Mariel Ferrucci, Silvia;
Grattan, Clive;
Vestergaard, Christian;
Zuberbier, Torsten;
Maurer, Marcus;
Giménez‐Arnau, Ana Maria

Publication type:

Article

A robust mRNA signature obtained via recursive ensemble feature selection predicts the responsiveness of omalizumab in moderate‐to‐severe asthma.

Published in:

Clinical & Translational Allergy, 2023, v. 13, n. 11, p. 1, doi. 10.1002/clt2.12306

By:

Kidwai, Sarah;
Barbiero, Pietro;
Meijerman, Irma;
Tonda, Alberto;
Perez‐Pardo, Paula;
Lio ́, Pietro;
van der Maitland‐Zee, Anke H.;
Oberski, Daniel L.;
Kraneveld, Aletta D.;
Lopez‐Rincon, Alejandro

Publication type:

Article

Omalizumab prevents respiratory illnesses in non‐atopic chronic spontaneous urticaria patients: A prospective, parallel‐group, pilot pragmatic trial.

Published in:

Clinical & Translational Allergy, 2023, v. 13, n. 7, p. 1, doi. 10.1002/clt2.12279

By:

Konstantinou, George N.;
Podder, Indrashis;
Karapiperis, Dimitrios

Publication type:

Article

Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response.

Published in:

Clinical & Translational Allergy, 2023, v. 13, n. 3, p. 1, doi. 10.1002/clt2.12227

By:

Gimeno, Ramón;
Ribas‐Llauradó, Clara;
Pesque, David;
Andrades, Evelyn;
Cenni, Bruno;
Ambros, Barbara;
Pujol, Ramon;
Giménez‐Arnau, Ana M.

Publication type:

Article

Pharmacokinetic equivalence of CT‐P39 and reference omalizumab in healthy individuals: A randomised, double‐blind, parallel‐group, Phase 1 trial.

Published in:

Clinical & Translational Allergy, 2022, v. 12, n. 11, p. 1, doi. 10.1002/clt2.12204

By:

Maurer, Marcus;
Saini, Sarbjit S.;
McLendon, Kristi;
Wabnitz, Paul;
Kim, Sunghyun;
Ahn, Keumyoung;
Kim, Suyoung;
Lee, Sewon;
Grattan, Clive

Publication type:

Article

Corrigendum: High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab.

Published in:: Clinical & Translational Allergy, 2022, v. 12, n. 2, p. 1, doi. 10.1002/clt2.12120
Publication type:: Article

IgE and high‐affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.

Published in:

Clinical & Translational Allergy, 2022, v. 12, n. 2, p. 1, doi. 10.1002/clt2.12117

By:

Giménez‐Arnau, Ana M.;
Ribas‐Llauradó, Clara;
Mohammad‐Porras, Nasser;
Deza, Gustavo;
Pujol, Ramón M.;
Gimeno, Ramón

Publication type:

Article

Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis.

Published in:

Clinical & Translational Allergy, 2022, v. 12, n. 1, p. 1, doi. 10.1002/clt2.12094

By:

Zhang, Yuan;
Xi, Lin;
Gao, Yunbo;
Huang, Yanran;
Cao, Feifei;
Xiong, Wei;
Wang, Chengshuo;
Zhang, Luo

Publication type:

Article

High‐dose non‐sedating antihistamines are used insufficiently in chronic urticaria patients treated with omalizumab.

Published in:

Clinical & Translational Allergy, 2021, v. 11, n. 10, p. 1, doi. 10.1002/clt2.12085

By:

Madsen, Hanne;
Mortz, Charlotte G.;
Bindslev‐Jensen, Carsten;
Reilev, Mette;
Hallas, Jesper;
Henriksen, Daniel P.

Publication type:

Article

Omalizumab for successful chemotherapy desensitisation: What we know so far.

Published in:

Clinical & Translational Allergy, 2021, v. 11, n. 10, p. 1, doi. 10.1002/clt2.12086

By:

Bumbacea, Roxana Silvia;
Ali, Selda;
Corcea, Sabina Loredana;
Spiru, Luiza;
Nitipir, Cornelia;
Strambu, Victor;
Bumbacea, Dragos

Publication type:

Article

COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports.

Published in:

2024

By:

D'Erme, Angelo Massimiliano;
Fidanzi, Cristian;
Romanelli, Marco;
Dini, Valentina;
Bagnoni, Giovanni;
Janowska, Agata

Publication type:

Case Study

COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports.

Published in:

Dermatology Reports, 2024, v. 16, n. 2, p. 1, doi. 10.4081/dr.2023.9763

By:

D'Erme, Angelo Massimiliano;
Fidanzi, Cristian;
Romanelli, Marco;
Dini, Valentina;
Bagnoni, Giovanni;
Janowska, Agata

Publication type:

Article

Clinical characteristics of complete responders versus non-complete responders to omalizumab, benralizumab and mepolizumab in patients with severe asthma: a long-term retrospective analysis.

Published in:

Annals of Medicine, 2024, v. 56, n. 1, p. 1, doi. 10.1080/07853890.2024.2317356

By:

Basagaña, Maria;
Martínez-Rivera, Carlos;
Padró, Clara;
Garcia-Olivé, Ignasi;
Martínez-Colls, Mimar;
Navarro, Juan;
Pardo, Laura;
Cruz, Paula;
Cardona Peitx, Gloria;
Carabias, Lídia;
Roger, Albert;
Abad, Jorge;
Rosell, Antoni

Publication type:

Article